Form 4 Tracker
Spyre Therapeutics, Inc.
SYRE

23 insider filings · Latest: Jun 25, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 1, 2026Jul 1 9:02 PMCAMERON TURTLE
Proposed Sale
45,000$88.78$4.0M

View →

Jun 25, 2026Jun 27 1:31 AMScott L BurrowsChief Financial Officer
Sale
15,000$87.13$1.3M97,994(D)

View →

Jun 25, 2026Jun 25 8:03 PMSCOTT BURROWS
Proposed Sale
15,000$87.13$1.3M

View →

Jun 23, 2026Jun 24 1:57 AMFairmount Healthcare Fund II L.P.
Proposed Sale
4,684,781$85.31$399.7M

View →

Jun 23, 2026Jun 24 1:56 AMFairmount Funds Management LLCDirector
Sale
4,684,781$85.31$399.7M0(I)

View →

Jun 22, 2026Jun 24 1:32 AMMichael Thomas HendersonDirector
Sale
20,000$100.00$2.0M68,606(D)

View →

Jun 22, 2026Jun 22 8:44 PMMICHAEL HENDERSON
Proposed Sale
20,000$88.34$1.8M

View →

Jun 3, 2026Jun 4 1:32 AMSheldon SloanChief Medical Officer
Sale
8,333$75.00$625.0K0(D)

View →

Jun 1, 2026Jun 4 1:31 AMCameron TurtleDirector, Chief Executive Officer
Sale
15,000$70.43$1.1M597,540(D)

View →

Jun 1, 2026Jun 4 1:30 AMScott L BurrowsChief Financial Officer
Sale
7,500$71.06$532.9K97,994(D)

View →

Jun 3, 2026Jun 3 8:27 PMSHELDON SLOAN
Proposed Sale
16,667$69.16$1.2M

View →

May 8, 2026May 9 1:31 AMMichael Thomas HendersonDirector
Sale
80,000$74.40$6.0M88,606(D)

View →

May 8, 2026May 8 8:22 PMMICHAEL HENDERSON
Proposed Sale
80,000$73.10$5.8M

View →

May 1, 2026May 2 1:35 AMScott L BurrowsChief Financial Officer
Sale
12,500$71.37$892.1K97,994(D)

View →

May 1, 2026May 2 1:34 AMSheldon SloanChief Medical Officer
Sale
78,333$71.50$5.6M0(D)

View →

May 1, 2026May 2 1:34 AMCameron TurtleDirector, Chief Executive Officer
Sale
15,000$71.37$1.1M612,540(D)

View →

May 1, 2026May 1 8:44 PMSHELDON SLOAN
Proposed Sale
78,333$74.45$5.8M

View →

May 1, 2026May 1 8:44 PMSCOTT BURROWS
Proposed Sale
27,500$74.45$2.0M

View →

Apr 1, 2026Apr 4 1:30 AMCameron TurtleDirector, Chief Executive Officer
Sale
15,000$49.33$739.9K627,540(D)

View →

Apr 1, 2026Apr 4 1:30 AMSheldon SloanChief Medical Officer
Sale
7,958$50.00$397.9K0(D)

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 25, 2026Jun 27 1:31 AMScott L BurrowsChief Financial Officer
Option Exercise
15,000$14.50359,857(D)

View →

Jun 23, 2026Jun 24 1:56 AMFairmount Funds Management LLCDirector
Conversion
16,6670(I)

View →

Jun 3, 2026Jun 4 1:32 AMSheldon SloanChief Medical Officer
Option Exercise
8,333$27.46313,334(D)

View →

Jun 1, 2026Jun 4 1:30 AMScott L BurrowsChief Financial Officer
Option Exercise
7,500$14.50374,857(D)

View →

May 27, 2026May 29 9:58 PMFairmount Funds Management LLCDirector
Grant/Award
8,026$72.518,026(I)

View →

May 27, 2026May 29 9:56 PMJeffrey W. AlbersDirector
Grant/Award
8,026$72.518,026(D)

View →

May 27, 2026May 29 9:55 PMMichael Thomas HendersonDirector
Grant/Award
8,026$72.518,026(D)

View →

May 27, 2026May 29 9:55 PMLaurie StelzerDirector
Grant/Award
8,026$72.518,026(D)

View →

May 27, 2026May 29 9:55 PMMark C. MckennaDirector
Grant/Award
8,026$72.518,026(D)

View →

May 27, 2026May 29 9:54 PMSandra MilliganDirector
Grant/Award
8,026$72.518,026(D)

View →

May 1, 2026May 2 1:35 AMScott L BurrowsChief Financial Officer
Option Exercise
12,500$14.50382,357(D)

View →

May 1, 2026May 2 1:34 AMSheldon SloanChief Medical Officer
Option Exercise
78,333$27.46321,667(D)

View →

Apr 1, 2026Apr 4 1:30 AMSheldon SloanChief Medical Officer
Option Exercise
7,958$21.6687,542(D)

View →

Apr 1, 2026Apr 4 1:29 AMScott L BurrowsChief Financial Officer
Option Exercise
7,500$14.50394,857(D)

View →

Mar 3, 2026Mar 4 2:32 AMScott L BurrowsChief Financial Officer
Option Exercise
2,500$14.50402,357(D)

View →